This is a fascinating aspect as the subgroup of T2D‐patients with severe insulin resistance is more susceptible to develop DKD,70 raising a question whether intensive treatment of these patients with metformin, or in future, with more potent SHIP2 inhibitors, could provide an effective means to prevent the development and progression of this fierce complication. Here, INPPL1 is linked to type 2 diabetes mellitus.